ClinicalTrials.gg
CompletedNCT04760457SMISUpdated May 10, 2023

Mandibular Overdentures Retained by Mini Implants: a Clinical Trial Comparing Different Surgical and Loading Protocols

An interventional study of Implant placement with flapped surgery and Implant placement with flapless surgery in Edentulous Mouth and Complete Edentulism, sponsored by Universidade Federal de Goias. Completed at 1 site in Brazil. Per ClinicalTrials.gov, last updated 2023-05-10.

Sponsored by Universidade Federal de Goias · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
74
Allocation
Randomized
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-20

Among 13 studies in Mouth, Edentulous with a site in Brazil — none open to participants now, none under way, none of them phase 3. Mouth, Edentulous · Brazil.

Enrollment
5th of 13
74 · median 60
Started
2021
the only one that year
No phase
12 of 13
none open now
Registered
13th of 13
by date
Lead sponsor
5 of 13
Universidade Federal de Goias

Among the 13 studies in Mouth, Edentulous with a site in Brazil, this one is the 5th largest by enrollment, is the only one that started in 2021, is one of 12 with no phase, and was the 13th registered.

Mouth, Edentulous

124 studies on the registry are indexed under Mouth, Edentulous; 17 are open to participants now.

Browse Mouth, Edentulous studies →

Open to participants now

None of the 13 studies in Mouth, Edentulous with a site in Brazil is open now. The open studies under Mouth, Edentulous, anywhere →

Who these studies take

Of the 11 Mouth, Edentulous studies recruiting now, 6 (55%) set no upper age limit and 5 (45%) stop at 75 or younger; none take children under 18; 6 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 13 studies in Mouth, Edentulous with a site in Brazil as a file.
02

Study summary

This study aims to test the combined effects of different loading protocols and surgical approaches on clinical and patient-reported outcome measures (PROMs) following the use of four mini implants for mandibular overdenture retention.

The main study hypotheses are:

  1. There are significant improvements in PROMs following implant intervention compared to baseline measures;
  2. Immediately loaded mini implants have similar failure rates compared to mini implants receiving a delayed 6-week protocol.
  3. Flapless surgery has similar post-insertion outcomes compared to flapped surgery.
Read the detailed description

This study aims to test the combined effects of different loading protocols and surgical approaches on clinical and patient-reported outcome measures (PROMs) following the use of four mini implants for mandibular overdenture retention.

Main study hypotheses:

  1. There are significant improvements in PROMs following implant intervention compared to baseline measures;
  2. Immediately loaded mini implants have similar failure rates compared to mini implants receiving a delayed 6-week protocol;
  3. Flapless surgery has similar post-insertion outcomes compared to flapped surgery.

Statement of clinical relevance:

Mini implants are an alternative to standard implants for overdentures. They are suitable for insertion in narrow ridges, are less invasive, simpler, less costly, and faster to perform, and are especially advantageous for older and frail patients who would benefit from more conservative and less burdensome treatments. Although previous studies reported favorable outcomes regarding patient oral comfort and function, there is a need for implant/attachment systems with higher predictability on implant survival and retention performance in the long-term. This study aims to provide clinical evidence on the newly developed 2.4mm one-piece TiZr mini implant with a miniaturized carbon-based coating attachment.

Methods:

This is a randomized clinical trial using a factorial design, to test the effectiveness of a mandibular overdenture retained by four mini implants. Participants will be randomized using a 2×2 factorial design: immediate/delayed loading (factor 1) and flapless/flapped surgery (factor 2). New conventional complete dentures will be provided as the baseline treatment. Next, eligible participants will be those who completed a 6-month period of denture usage, and are in need of implants to improve the function of the mandibular denture. Imaging exam should present a minimum of 5.4 mm of ridge width in the interforaminal region (recommended for flapless surgery).

Included subjects to take part in the RCT will be randomized to the treatment groups according to the combined study factors - loading protocols: immediate (IL) or delayed (DL); and surgical approaches: flapless (FLS) or flapped (FPS) surgery. Hence, the combined factors will results in four groups:

  • IL/FLS (Group I)
  • IL/FPS (Group II)
  • DL/FLS (Group III)
  • DL/FPS (Group IV) Considering the patient's perspective this study design assumed a "worst" protocol (delayed and flapped - Group IV) and a "best" protocol (flapless and immediate - Group I) and two other intermediary conditions (flapped/immediate and flapless/delayed).

All participants will receive four Straumann® Mini Implant System (one-piece Tissue Level implants) with an Optiloc® prosthetic connection and PEEK matrix inserts. Surgery will follow the workflow for the surgical procedure for the Straumann® Mini Implant System concerning preoperative planning, implant bed preparation and implant insertion. For the prosthetic procedures, we will perform a chairside incorporation of the retentive inserts to convert the existing well-fitting and well-functioning lower denture into an overdenture with the Optiloc® Retentive System/Straumann® Mini Implants.

Outcomes will include short-term outcomes (Patient perceived burdens in surgery, postoperative swelling and pain, consumption of analgesics and surgical time) and long-term - 1-year (implant survival and success, peri-implant marginal bone level changes, PROMs, retention force, prosthodontic events) outcomes. Sample size calculation resulted in a total of 74 participants, 18 in each of the four groups. Data analysis will include descriptive and bivariate analyses, Kaplan-Meier curves and regression models using Generalized Estimating Equations (GEE) for longitudinal data.

03

Conditions studied

  • Edentulous Mouth
  • Complete Edentulism

Browse trials for

Keywords

  • Overdenture
  • Mini implant
  • Flapless surgery
  • Dental implant
  • Implant loading protocol
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • No for implant surgery (mainly related to uncontrolled systemic diseases);
  • Enough bone height in the interforaminal area for an implant length of at least 10 mm;
  • Ability to understand and answer the questionnaires used in the study and agree to participate by providing a written .

Exclusion criteria

Exclusion Criteria:

  • Noncompliant participants;
  • Disagreement to be randomly allocated to the treatment study groups;
  • Signs of untreated temporomandibular disorders or uncontrolled systemic or oral conditions that require additional treatments.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Outcomes assessor)
Enrollment
74 participants (actual)

Study arms

  • Active comparator
    IL-FLS

    Immediate loading (IL) and Flapless surgery (FLS)

    Procedure: Implant placement with flapless surgery · Procedure: Implant immediate loading

  • Active comparator
    IL-FPS

    Immediate loading (IL) and Flapped surgery (FPS)

    Procedure: Implant placement with flapped surgery · Procedure: Implant immediate loading

  • Active comparator
    DL-FLS

    Delayed loading (DL) and Flapless surgery (FLS)

    Procedure: Implant placement with flapless surgery · Procedure: Implant delayed loading

  • Active comparator
    DL-FPS

    Delayed loading (DL) and Flapped surgery (FPS)

    Procedure: Implant placement with flapped surgery · Procedure: Implant delayed loading

Interventions

  • ProcedureImplant placement with flapped surgery

    Four mini implants will be placed reflecting a flap.

  • ProcedureImplant placement with flapless surgery

    Four mini implants will be placed without reflecting a flap.

  • ProcedureImplant immediate loading

    Four mini implants will be immediately loaded.

  • ProcedureImplant delayed loading

    Four mini implants will be loaded after a 6-week healing period.

06

What researchers measure

Primary outcomes

  1. Patient-perceived burdens

    The Burdens in Oral Surgery Questionnaire (BiOS-Q) will be used to assess patient-perceived burdens. It includes 16 items concerning all aspects of procedures occurring during a surgery. Responses for each item are assessed using a visual analogue scale (VAS) ranging from 0 = no expression of the attribute (e.g. not unpleasant at all) to 100 = maximum expression (e.g. very unpleasant).

    Time frame: Twenty-four hours after implant surgery.

  2. Implant survival and success

    Each implant will be assessed according to the health scale of the International Congress of Oral Implantologists (ICOI-Pisa health scale). After clinical assessment, each implant will be classified as 'success', 'satisfactory survival', 'compromised survival' or 'failure'.

    Time frame: Incidence thoughout the 12-month follow-up after implant placement.

  3. Postoperative pain and discomfort

    A 100-cm graduated visual analog scale will be used to evaluate participants' assessments of pain and discomfort regarding the surgical process. Each participant will indicate their level of pain and discomfort with each parameter by marking a point along the scale.

    Time frame: Assessed 24 hours after implant placement.

  4. Postoperative pain and discomfort

    A 100-cm graduated visual analog scale will be used to evaluate participants' assessments of pain and discomfort regarding the surgical process. Each participant will indicate their level of pain and discomfort with each parameter by marking a point along the scale.

    Time frame: Assessed 72 hours after implant placement.

  5. Postoperative pain and discomfort

    A 100-cm graduated visual analog scale will be used to evaluate participants' assessments of pain and discomfort regarding the surgical process. Each participant will indicate their level of pain and discomfort with each parameter by marking a point along the scale.

    Time frame: Assessed 1 week after implant placement.

  6. Consumption of analgesics

    The number of analgesics consumed by the participant during the post-operative and healing period will be recorded in the patient's file.

    Time frame: Assessed until 1 week after implant placement.

  7. Patient Satisfaction

    The McGill Denture Satisfaction Instrument - DSI (Awad \& Feine, 1998; de Grandmont et al., 1994) will be used to assess patients' satisfaction relating to their prostheses. This is a treatment-specific patient-based outcome assessing satisfaction relating to several aspects of the mandibular prosthesis, including general satisfaction, comfort, stability, aesthetics, chewing ability (ease of chewing), chewing efficiency (ability to crush food in small particles), ease of cleaning, ability to speak and oral condition (condition of their mouth, which can refer to oral health status and was measured by "In general, are you satisfied with your oral condition?''. The subjects will answer on a 100 mm visual analogue scale (VAS) anchored by the words 'not at all satisfied' and 'extremely satisfied'.

    Time frame: Assessed at baseline (before implant surgery)

  8. Patient Satisfaction

    The McGill Denture Satisfaction Instrument - DSI (Awad \& Feine, 1998; de Grandmont et al., 1994) will be used to assess patients' satisfaction relating to their prostheses. This is a treatment-specific patient-based outcome assessing satisfaction relating to several aspects of the mandibular prosthesis, including general satisfaction, comfort, stability, aesthetics, chewing ability (ease of chewing), chewing efficiency (ability to crush food in small particles), ease of cleaning, ability to speak and oral condition (condition of their mouth, which can refer to oral health status and was measured by "In general, are you satisfied with your oral condition?''. The subjects will answer on a 100 mm visual analogue scale (VAS) anchored by the words 'not at all satisfied' and 'extremely satisfied'.

    Time frame: Assessed at the 3-month follow-up visit after implant placement.

  9. Patient Satisfaction

    The McGill Denture Satisfaction Instrument - DSI (Awad \& Feine, 1998; de Grandmont et al., 1994) will be used to assess patients' satisfaction relating to their prostheses. This is a treatment-specific patient-based outcome assessing satisfaction relating to several aspects of the mandibular prosthesis, including general satisfaction, comfort, stability, aesthetics, chewing ability (ease of chewing), chewing efficiency (ability to crush food in small particles), ease of cleaning, ability to speak and oral condition (condition of their mouth, which can refer to oral health status and was measured by "In general, are you satisfied with your oral condition?''. The subjects will answer on a 100 mm visual analogue scale (VAS) anchored by the words 'not at all satisfied' and 'extremely satisfied'.

    Time frame: Assessed at the 6-month follow-up visit after implant placement.

  10. Patient Satisfaction

    The McGill Denture Satisfaction Instrument - DSI (Awad \& Feine, 1998; de Grandmont et al., 1994) will be used to assess patients' satisfaction relating to their prostheses. This is a treatment-specific patient-based outcome assessing satisfaction relating to several aspects of the mandibular prosthesis, including general satisfaction, comfort, stability, aesthetics, chewing ability (ease of chewing), chewing efficiency (ability to crush food in small particles), ease of cleaning, ability to speak and oral condition (condition of their mouth, which can refer to oral health status and was measured by "In general, are you satisfied with your oral condition?''. The subjects will answer on a 100 mm visual analogue scale (VAS) anchored by the words 'not at all satisfied' and 'extremely satisfied'.

    Time frame: Assessed at the 12-month follow-up visit after implant placement.

  11. Oral health-related quality of life (OHRQoL)

    The cross-culturally adapted Brazilian version of the Oral Health Impact Profile for edentulous subjects (OHIP-EDENT) will be used. It contains 19 items divided in four different subscale domains: (I) masticatory discomfort and disability (four items), (II) psychological discomfort and disability (five items), (III) social disability (five items), and (IV) oral pain and discomfort (five items). The items are answerable by a 3-point Likert scale and responses will be summed to result an overall score. Higher scores represent worse OHRQoL.

    Time frame: Assessed at baseline (before implant surgery).

  12. Oral health-related quality of life (OHRQoL)

    The cross-culturally adapted Brazilian version of the Oral Health Impact Profile for edentulous subjects (OHIP-EDENT) will be used. It contains 19 items divided in four different subscale domains: (I) masticatory discomfort and disability (four items), (II) psychological discomfort and disability (five items), (III) social disability (five items), and (IV) oral pain and discomfort (five items). The items are answerable by a 3-point Likert scale and responses will be summed to result an overall score. Higher scores represent worse OHRQoL.

    Time frame: Assessed at the 3-month follow-up visit after implant placement.

  13. Oral health-related quality of life (OHRQoL)

    The cross-culturally adapted Brazilian version of the Oral Health Impact Profile for edentulous subjects (OHIP-EDENT) will be used. It contains 19 items divided in four different subscale domains: (I) masticatory discomfort and disability (four items), (II) psychological discomfort and disability (five items), (III) social disability (five items), and (IV) oral pain and discomfort (five items). The items are answerable by a 3-point Likert scale and responses will be summed to result an overall score. Higher scores represent worse OHRQoL.

    Time frame: Assessed at the 6-month follow-up visit after implant placement.

  14. Oral health-related quality of life (OHRQoL)

    The cross-culturally adapted Brazilian version of the Oral Health Impact Profile for edentulous subjects (OHIP-EDENT) will be used. It contains 19 items divided in four different subscale domains: (I) masticatory discomfort and disability (four items), (II) psychological discomfort and disability (five items), (III) social disability (five items), and (IV) oral pain and discomfort (five items). The items are answerable by a 3-point Likert scale and responses will be summed to result an overall score. Higher scores represent worse OHRQoL.

    Time frame: Assessed at the 12-month follow-up visit after implant placement.

  15. Prosthodontic maintenance events

    The incidence of prosthodontic repair/adjustment events will be recorded during the clinical assessments.

    Time frame: Throughout 12 months after overdenture delivery.

  16. Surgical time

    The time interval concerning the clinical visit for implant placement and delivery of the overdenture or denture adaptation will me measured and registered.

    Time frame: Procedure (Assessed during the clinical visit of implant placement and overdenture delivery or denture adaptation.)

Secondary outcomes

  1. Masticatory Performance

    To perform the masticatory performance test two gums in a dragée form will be used, one blue and one pink, which need to be stuck together manually by wetting them with water and applying moderate force. The participants will be instructed to chew 2 samples of the gum on theirs preferred chewing side for 20 and 50 chewing cycles, respectively, leaving an interval of 1 minute between each chewing sequence.

    Time frame: Assessed at baseline (before implant surgery).

  2. Masticatory Performance

    To perform the masticatory performance test two gums in a dragée form will be used, one blue and one pink, which need to be stuck together manually by wetting them with water and applying moderate force. The participants will be instructed to chew 2 samples of the gum on theirs preferred chewing side for 20 and 50 chewing cycles, respectively, leaving an interval of 1 minute between each chewing sequence.

    Time frame: Assessed at the 3-month follow-up visit after implant placement.

  3. Masticatory Performance

    To perform the masticatory performance test two gums in a dragée form will be used, one blue and one pink, which need to be stuck together manually by wetting them with water and applying moderate force. The participants will be instructed to chew 2 samples of the gum on theirs preferred chewing side for 20 and 50 chewing cycles, respectively, leaving an interval of 1 minute between each chewing sequence.

    Time frame: Assessed at the 6-month follow-up visit after implant placement.

  4. Masticatory Performance

    To perform the masticatory performance test two gums in a dragée form will be used, one blue and one pink, which need to be stuck together manually by wetting them with water and applying moderate force. The participants will be instructed to chew 2 samples of the gum on theirs preferred chewing side for 20 and 50 chewing cycles, respectively, leaving an interval of 1 minute between each chewing sequence.

    Time frame: Assessed at the 12-month follow-up visit after implant placement.

  5. Maximum voluntary bite force

    Maximum voluntary bite force will be measured with a digital gauge (IDDK - Kratos, Cotia, São Paulo, Brazil) in the region of the first molar with three assessments per side.

    Time frame: Assessed at baseline (before implant surgery).

  6. Maximum voluntary bite force

    Maximum voluntary bite force will be measured with a digital gauge (IDDK - Kratos, Cotia, São Paulo, Brazil) in the region of the first molar with three assessments per side.

    Time frame: Assessed at the 3-month follow-up visit after implant placement.

  7. Maximum voluntary bite force

    Maximum voluntary bite force will be measured with a digital gauge (IDDK - Kratos, Cotia, São Paulo, Brazil) in the region of the first molar with three assessments per side.

    Time frame: Assessed at the 6-month follow-up visit after implant placement.

  8. Maximum voluntary bite force

    Maximum voluntary bite force will be measured with a digital gauge (IDDK - Kratos, Cotia, São Paulo, Brazil) in the region of the first molar with three assessments per side.

    Time frame: Assessed at the 12-month follow-up visit after implant placement.

  9. Peri-implant bone change

    Periapical radiographs will be obtained and the peri-implant bone level will be measured and compared longitudinally.

    Time frame: Peri-implant bone loss at the 3-month follow-up compared to initial stage (1-week rediograph).

  10. Peri-implant bone change

    Periapical radiographs will be obtained and the peri-implant bone level will be measured and compared longitudinally.

    Time frame: Peri-implant bone loss at the 6-month follow-up compared to initial stage (1-week rediograph).

  11. Peri-implant bone change

    Periapical radiographs will be obtained and the peri-implant bone level will be measured and compared longitudinally.

    Time frame: Peri-implant bone loss at the 12-month follow-up compared to initial stage (1-week rediograph).

  12. Bleeding on probing

    Incidence of inflammation of the peri-implant soft tissues

    Time frame: Assessed at 6-month post-insertion

  13. Bleeding on probing

    Incidence of inflammation of the peri-implant soft tissues

    Time frame: Assessed at 12-month post-insertion

  14. Probing depth

    Level of the peri-implant sulcus (in milimiters)

    Time frame: Assessed at 6-month post-insertion

  15. Probing depth

    Level of the peri-implant sulcus (in milimiters)

    Time frame: Assessed at 12-month post-insertion

  16. Suppuration

    Incidence of suppuration on probing the peri-implant soft tissues

    Time frame: Assessed at 6-month post-insertion

  17. Suppuration

    Incidence of suppuration on probing the peri-implant soft tissues

    Time frame: Assessed at 12-month post-insertion

07

Study locations

1 site
  • School of Dentistry, Federal University of Goias
    Goiânia, Goias 74605-220, Brazil
08

References and documents

Publications

  • Awad MA, Feine JS. Measuring patient satisfaction with mandibular prostheses. Community Dent Oral Epidemiol. 1998 Dec;26(6):400-5. doi: 10.1111/j.1600-0528.1998.tb01978.x. PubMed 9870539 ↗
  • de Grandmont P, Feine JS, Tache R, Boudrias P, Donohue WB, Tanguay R, Lund JP. Within-subject comparisons of implant-supported mandibular prostheses: psychometric evaluation. J Dent Res. 1994 May;73(5):1096-104. doi: 10.1177/00220345940730051201. PubMed 8006237 ↗
  • Demain S, Goncalves AC, Areia C, Oliveira R, Marcos AJ, Marques A, Parmar R, Hunt K. Living with, managing and minimising treatment burden in long term conditions: a systematic review of qualitative research. PLoS One. 2015 May 29;10(5):e0125457. doi: 10.1371/journal.pone.0125457. eCollection 2015. PubMed 26024379 ↗
  • Enkling N, Saftig M, Worni A, Mericske-Stern R, Schimmel M. Chewing efficiency, bite force and oral health-related quality of life with narrow diameter implants - a prospective clinical study: results after one year. Clin Oral Implants Res. 2017 Apr;28(4):476-482. doi: 10.1111/clr.12822. Epub 2016 Mar 24. PubMed 27009835 ↗
  • Enkling N, Haueter M, Worni A, Muller F, Leles CR, Schimmel M. A prospective cohort study on survival and success of one-piece mini-implants with associated changes in oral function: Five-year outcomes. Clin Oral Implants Res. 2019 Jun;30(6):570-577. doi: 10.1111/clr.13444. Epub 2019 May 8. PubMed 31021481 ↗
  • Kanazawa M, Feine J, Esfandiari S. Clinical guidelines and procedures for provision of mandibular overdentures on 4 mini-dental implants. J Prosthet Dent. 2017 Jan;117(1):22-27. doi: 10.1016/j.prosdent.2016.04.020. Epub 2016 Aug 1. PubMed 27492988 ↗
  • Klein MO, Schiegnitz E, Al-Nawas B. Systematic review on success of narrow-diameter dental implants. Int J Oral Maxillofac Implants. 2014;29 Suppl:43-54. doi: 10.11607/jomi.2014suppl.g1.3. PubMed 24660189 ↗
  • Leao A, Sheiham A. Relation between clinical dental status and subjective impacts on daily living. J Dent Res. 1995 Jul;74(7):1408-13. doi: 10.1177/00220345950740071301. PubMed 7560392 ↗
  • Leao A, Sheiham A. The development of a socio-dental measure of dental impacts on daily living. Community Dent Health. 1996 Mar;13(1):22-6. PubMed 8634892 ↗
  • Lemos CA, Verri FR, Batista VE, Junior JF, Mello CC, Pellizzer EP. Complete overdentures retained by mini implants: A systematic review. J Dent. 2017 Feb;57:4-13. doi: 10.1016/j.jdent.2016.11.009. Epub 2016 Nov 22. PubMed 27888049 ↗
  • Marcello-Machado RM, Faot F, Schuster AJ, Nascimento GG, Del Bel Cury AA. Mini-implants and narrow diameter implants as mandibular overdenture retainers: A systematic review and meta-analysis of clinical and radiographic outcomes. J Oral Rehabil. 2018 Feb;45(2):161-183. doi: 10.1111/joor.12585. Epub 2017 Dec 2. PubMed 29125652 ↗
  • Reissmann DR, Semmusch J, Farhan D, Smeets R, Heiland M, Heydecke G. Development and validation of the Burdens in Oral Surgery Questionnaire (BiOS-Q). J Oral Rehabil. 2013 Oct;40(10):780-7. doi: 10.1111/joor.12092. Epub 2013 Aug 27. PubMed 24033878 ↗
  • Reissmann DR, Enkling N, Moazzin R, Haueter M, Worni A, Schimmel M. Long-term changes in oral health-related quality of life over a period of 5 years in patients treated with narrow diameter implants: A prospective clinical study. J Dent. 2018 Aug;75:84-90. doi: 10.1016/j.jdent.2018.05.019. Epub 2018 May 28. PubMed 29852211 ↗
  • Schiegnitz E, Al-Nawas B. Narrow-diameter implants: A systematic review and meta-analysis. Clin Oral Implants Res. 2018 Oct;29 Suppl 16:21-40. doi: 10.1111/clr.13272. PubMed 30328192 ↗
  • Souza RF, Patrocinio L, Pero AC, Marra J, Compagnoni MA. Reliability and validation of a Brazilian version of the Oral Health Impact Profile for assessing edentulous subjects. J Oral Rehabil. 2007 Nov;34(11):821-6. doi: 10.1111/j.1365-2842.2007.01749.x. PubMed 17919248 ↗
  • Misch CE, Perel ML, Wang HL, Sammartino G, Galindo-Moreno P, Trisi P, Steigmann M, Rebaudi A, Palti A, Pikos MA, Schwartz-Arad D, Choukroun J, Gutierrez-Perez JL, Marenzi G, Valavanis DK. Implant success, survival, and failure: the International Congress of Oral Implantologists (ICOI) Pisa Consensus Conference. Implant Dent. 2008 Mar;17(1):5-15. doi: 10.1097/ID.0b013e3181676059. PubMed 18332753 ↗

Individual participant data

Plan to share: Yes — Clinical data will be implemented electronically using a dedicated electronic data capturing (EDC) system (REDCap DMS, https://www.project-redcap.org/), hosted by the server infrastructure of the Federal University of Goias. Data will be entered in REDCap using either the web-based application or the REDCap mobile app for iOS/Android. Baseline and longitudinal health-related data, and patient identifying codes used for the analysis will be entered in a REDCap database. The Report Builder will be used to create customized reports that are queried in real time.

Supporting information: Study protocol

Time frame: Data will be available after publication of the results in high-impact journals, and until two years hereafter

Access criteria: Upon request to the study coordinator

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2021 to primary completion in Nov 2022, 20 months.

Of 46 non-industry interventional studies with no phase under Mouth, Edentulous, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 30. This study's 20 months is below that.

Counting every sponsor, half of 54 studies reached it within 24 months; a quarter within 12 and three quarters within 51.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 27, 2021
First posted
Feb 18, 2021
StartActual
Mar 1, 2021
Primary completionActual
Nov 30, 2022
CompletionActual
Nov 30, 2022
Last update
May 10, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 10, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04760457
Lead sponsor
Universidade Federal de Goias
Collaborators
ITI International Team for Implantology, Switzerland, Institut Straumann AG
Responsible party
Cláudio Rodrigues Leles (Full Professor, Universidade Federal de Goias) — Principal investigator
First posted
Feb 18, 2021
Start date
Mar 1, 2021
Primary completion
Nov 30, 2022
Completion
Nov 30, 2022
Last update
May 10, 2023

Study contacts

Claudio R Leles, DDS, PhD
study director · Universidade Federal de Goias

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion